Recombination and allelic association in the Xq/Yq homology region

Human Molecular Genetics
L Li, D H Hamer

Abstract

The ends of the long arms of the human X and Y chromosomes contain a homologous region that can undergo sequence exchange. We have developed new polymorphic markers to analyze the genetic behavior of this region in the three-generation CEPH reference families. These Xq/Yq markers undergo crossovers in approximately 2% of male meioses in a pattern consistent with reciprocal recombination rather than gene conversion. Although the rate of recombination in males is significantly higher than in females or in autosomal sequences, it is more than an order of magnitude lower than in the short arm pseudoautosomal region at Xp/Yp. The Xq/Yq markers exhibit allelic association with one another, but not with markers in the X-specific or Y-specific regions of the sex chromosomes. Hence the Xq/Yq homology region displays behavior that is intermediate between sex-linked and true pseudoautosomal, and is unlikely to be essential for proper chromosome segregation.

Citations

Jan 13, 1998·Biochimica Et Biophysica Acta·A B RaitanoC L Sawyers
Nov 21, 1998·Biochimica Et Biophysica Acta·M Ruas, G Peters
Nov 24, 1999·Gene·M R MatarazzoM D'Esposito
Apr 10, 2008·European Journal of Human Genetics : EJHG·Antonia FlaquerChristine Fischer
Feb 5, 2003·Genome Research·Fadi J CharcharJennifer A Marshall Graves
Jul 4, 2012·Fertility and Sterility·Merel MaiburgJacques Giltay
May 3, 2006·Current Opinion in Genetics & Development·Rüdiger Jörg Blaschke, Gudrun Rappold
Oct 16, 1999·American Journal of Human Genetics·M Horwitz, P H Wiernik
Mar 22, 2005·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·E S D de PauwH J Tanke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.